<h3>领取 TipRanks 高级版 70% 折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>来自 Sunho Biologics, Inc. (HK:2898) 的公告现已发布。</p>
<p>Sunho Biologics, Inc. 宣布，刘松博士已于 2026 年 2 月 28 日辞去执行董事、首席执行官和首席科学官职务，以追求其他个人和职业机会。刘博士表示与董事会没有分歧，也没有任何需要股东关注的事项，他将在离职前继续尽职尽责，以确保平稳过渡，同时公司将寻找合适的人选填补首席执行官和首席科学官的职位，这标志着公司领导层的重大变动，可能会影响其战略和科学方向。</p>
<p>(HK:2898) 股票的最新分析师评级为持有，目标价为 HK$7.00。要查看 Sunho Biologics, Inc. 股票的完整分析师预测列表，请参见 HK:2898 股票预测页面。</p>
<p><strong>关于 Sunho Biologics, Inc. 的更多信息</strong></p>
<p>Sunho Biologics, Inc. 是一家在香港证券交易所上市并注册于开曼群岛的生物技术公司，专注于开发生物治疗，其治理由包括执行董事、非执行董事和独立非执行董事在内的董事会领导。</p>
<p><strong>平均交易量：</strong> 10,551</p>
<p><strong>技术情绪信号：</strong> 强烈买入</p>
<p><strong>当前市值：</strong> HK$1.13B</p>
<p>在 TipRanks 的股票分析页面上找到关于 2898 股票的详细分析。</p>

<p>Sunho Biologics, Inc. 宣布，尹流松博士将于 2026 年 2 月 28 日辞去首席执行官和首席科学官职务，以追求其他机会。他表示与董事会没有分歧，并将确保在公司寻找接替人选期间顺利过渡。这一领导层变动可能会影响公司的战略方向。目前，Sunho Biologics（HK:2898）的分析师评级为持有，目标价格为 7.00 港元</p>

<h3>Claim 70% Off TipRanks Premium</h3>
<div class="lb-trans"><h3>领取 TipRanks 高级版 70% 折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>An announcement from Sunho Biologics,Inc. ( (HK:2898) ) is now available.</p>
<div class="lb-trans"><p>来自 Sunho Biologics, Inc. (HK:2898) 的公告现已发布。</p>
</div><p>Sunho Biologics, Inc. announced that Dr. Yin Liusong has tendered his resignation as executive director, chief executive officer and chief scientific officer, effective 28 February 2026, to pursue other personal and career opportunities. Dr. Yin has indicated there is no disagreement with the board or any matter requiring shareholder attention, and he will continue to perform his duties diligently until his departure to ensure a smooth transition, while the company seeks suitable candidates to fill the CEO and chief scientific officer roles, signaling a significant leadership change that may influence its strategic and scientific direction.</p>
<div class="lb-trans"><p>Sunho Biologics, Inc. 宣布，刘松博士已于 2026 年 2 月 28 日辞去执行董事、首席执行官和首席科学官职务，以追求其他个人和职业机会。刘博士表示与董事会没有分歧，也没有任何需要股东关注的事项，他将在离职前继续尽职尽责，以确保平稳过渡，同时公司将寻找合适的人选填补首席执行官和首席科学官的职位，这标志着公司领导层的重大变动，可能会影响其战略和科学方向。</p>
</div><p>The most recent analyst rating on (HK:2898) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Sunho Biologics,Inc. stock, see the HK:2898 Stock Forecast page.</p>
<div class="lb-trans"><p>(HK:2898) 股票的最新分析师评级为持有，目标价为 HK$7.00。要查看 Sunho Biologics, Inc. 股票的完整分析师预测列表，请参见 HK:2898 股票预测页面。</p>
</div><p><strong>More about Sunho Biologics,Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Sunho Biologics, Inc. 的更多信息</strong></p>
</div><p>Sunho Biologics, Inc. is a biotechnology company listed on the Hong Kong Stock Exchange and incorporated in the Cayman Islands, focused on developing biologic therapies, with its governance led by a board comprising executive, non-executive and independent non-executive directors.</p>
<div class="lb-trans"><p>Sunho Biologics, Inc. 是一家在香港证券交易所上市并注册于开曼群岛的生物技术公司，专注于开发生物治疗，其治理由包括执行董事、非执行董事和独立非执行董事在内的董事会领导。</p>
</div><p><strong>Average Trading Volume:</strong> 10,551</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 10,551</p>
</div><p><strong>Technical Sentiment Signal:</strong> Strong Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 强烈买入</p>
</div><p><strong>Current Market Cap:</strong> HK$1.13B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> HK$1.13B</p>
</div><p>Find detailed analytics on 2898 stock on TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>在 TipRanks 的股票分析页面上找到关于 2898 股票的详细分析。</p>
</div>

盛禾生物的首席执行官兼首席科学官刘松博士将辞职